文献速递关节外科

多中心前瞻性临床研究中两种全膝关节置换系统的髌股并发症发生率比较

Comparative Incidence of Patellofemoral Complications Between 2 Total Knee Arthroplasty Systems in a Multicenter, Prospective Clinical Study.
PubMed 文献 · J Arthroplasty · 2017-04-20

在多中心前瞻性研究中,比较新型全膝关节置换系统(NEW-TKA)与现有全膝关节置换系统(CA-TKA)的髌股并发症(PCC)和髌股症状性骨擦感(SC)累积发生率。NEW-TKA组PCC的1年和2年累积发生率分别为3.15%和4.11%,低于CA-TKA组的6.15%和8.26%;SC的2年累积发生率NEW-TKA组为1.21%,低于CA-TKA组的3.67%,差异有统计学意义。

要点

  • NEW-TKA组PCC的2年累积发生率为4.11%,低于CA-TKA组的8.26%(log-rank P=.018)。
  • NEW-TKA组2年内SC累积发生率为1.21%,低于CA-TKA组的3.67%(log-rank P=.017)。
  • NEW-TKA组PCC和SC的1年及2年累积发生率均不足CA-TKA组的一半。

核心结论

  • NEW-TKA组PCC和SC的1年及2年中期累积发生率均不足CA-TKA组的一半,作者认为这对该新型植入物是有希望的趋势。

研究设计与样本

  • 多中心前瞻性临床研究,22名研究者前瞻性纳入704例CA-TKA患者,其中364例接受后稳定型配置。
  • 23名研究者(其中19名来自CA-TKA研究)纳入1138例NEW-TKA患者,其中584例接受后稳定型配置。
  • 采用Kaplan-Meier法估算累积发生率(CIR)。

主要发现

  • CA-TKA组发生32例PCC,1年CIR为6.15%,2年CIR为8.26%。
  • NEW-TKA组发生19例PCC,1年CIR为3.15%,2年CIR为4.11%。
  • CA-TKA组发生15例SC,其中12例发生在2年内,CIR为3.67%。
  • NEW-TKA组2年内发生5例SC,CIR为1.21%。
  • NEW-TKA组总体PCC和SC的CIR均统计学显著低于CA-TKA组(log-rank P值:PCC为.018,SC为.017)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cumulative incidence rates (CIRs) of patellofemoral complications (PCCs) and patellofemoral symptomatic crepitus (SC) using a new knee system-total knee arthroplasty (NEW-TKA) were compared with those of a currently available product-total knee arthroplasty (CA-TKA). METHODS: Twenty-two investigators prospectively enrolled 704 patients into a study using CA-TKA; 364 received a posterior-stabilized configuration. Twenty-three investigators (19 from the CA-TKA study) enrolled 1138 patients with NEW-TKA; 584 received a posterior-stabilized configuration. CIRs were estimated with Kaplan-Meier methods. RESULTS: CA-TKA had 32 PCCs (6.15% CIR at 1 year and 8.26% at 2 years). NEW-TKA had 19 PCCs (3.15% CIR at 1 year and 4.11% at 2 years). CA-TKA had 15 SCs, 12 before 2 years (CIR = 3.67%); NEW-TKA had 5 SCs before 2 years (CIR = 1.21%). NEW-TKA had a statistically lower CIR of overall PCC and SC (log-rank P values = .018 for PCC and .017 for SC). CONCLUSION: Interim 1- and 2-year CIRs of PCC and SC in NEW-TKA were less than half of those for CA-TKA, which is a promising trend for this new implant.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Toomey SD, Daccach JA, Shah JC, et al. Comparative Incidence of Patellofemoral Complications Between 2 Total Knee Arthroplasty Systems in a Multicenter, Prospective Clinical Study. J Arthroplasty. 2017. PMID: 28600108. doi:10.1016/j.arth.2017.04.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。